These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16495774

  • 1. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
    Liou YJ, Lai IC, Lin MW, Bai YM, Lin CC, Liao DL, Chen JY, Lin CY, Wang YC.
    Pharmacogenet Genomics; 2006 Mar; 16(3):151-7. PubMed ID: 16495774
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z, Hou G, Zhang X, Yao H, Sha W, Zhang X.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [Abstract] [Full Text] [Related]

  • 3. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY.
    J Diabetes Complications; 2008 Apr; 22(5):331-8. PubMed ID: 18413207
    [Abstract] [Full Text] [Related]

  • 4. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
    Tiwari AK, Deshpande SN, Lerer B, Nimgaonkar VL, Thelma BK.
    Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
    [Abstract] [Full Text] [Related]

  • 5. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, Dorevitch A, Yakir A, Greenberg D, Lerner A, Lerer B.
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [Abstract] [Full Text] [Related]

  • 6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Petronis A, Kennedy JL.
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [Abstract] [Full Text] [Related]

  • 7. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene polymorphisms and the risk of ischemic stroke.
    Saidi S, Mallat SG, Almawi WY, Mahjoub T.
    Acta Neurol Scand; 2010 Feb; 121(2):114-9. PubMed ID: 19804474
    [Abstract] [Full Text] [Related]

  • 8. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, Lerer B, Nimagaonkar VL, Thelma BK.
    Pharmacogenomics J; 2005 Feb; 5(1):60-9. PubMed ID: 15505641
    [Abstract] [Full Text] [Related]

  • 9. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.
    Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Sikdar S, Gupta M, Javed S, Pasha MA.
    Free Radic Biol Med; 2008 Jun 01; 44(11):1912-8. PubMed ID: 18325347
    [Abstract] [Full Text] [Related]

  • 10. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
    Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY.
    Clin Endocrinol (Oxf); 2008 Apr 01; 68(4):542-6. PubMed ID: 17973941
    [Abstract] [Full Text] [Related]

  • 11. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML.
    Pharmacopsychiatry; 2003 Apr 01; 36(2):73-8. PubMed ID: 12734765
    [Abstract] [Full Text] [Related]

  • 12. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy.
    Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H, Tanus-Santos JE.
    J Hypertens; 2006 Dec 01; 24(12):2393-7. PubMed ID: 17082721
    [Abstract] [Full Text] [Related]

  • 13. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.
    Acta Pharmacol Sin; 2006 Mar 01; 27(3):328-32. PubMed ID: 16490169
    [Abstract] [Full Text] [Related]

  • 14. [Association of genetic polymorphisms in endothelial nitric oxide synthase 3 gene with recurrent early spontaneous abortion].
    Fan W, Li SW, Wang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb 01; 24(1):23-6. PubMed ID: 17285538
    [Abstract] [Full Text] [Related]

  • 15. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG, Choi JE, An H, Lim SW, Lee HJ, Han C, Kim YK, Kim SH, Cho SN, Lee MS, Joe SH, Jung IK, Kim L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1545-8. PubMed ID: 18602732
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.
    Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB.
    Gynecol Oncol; 2004 Jun 01; 93(3):686-90. PubMed ID: 15196865
    [Abstract] [Full Text] [Related]

  • 17. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
    Zai CC, Tiwari AK, Basile V, De Luca V, Müller DJ, King N, Voineskos AN, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL.
    Pharmacogenomics J; 2009 Jun 01; 9(3):168-74. PubMed ID: 19238168
    [Abstract] [Full Text] [Related]

  • 18. Haplotype analysis of the endothelial nitric oxide synthase gene in asthma.
    Holla LI, Jurajda M, Pohunek P, Znojil V.
    Hum Immunol; 2008 Jun 01; 69(4-5):306-13. PubMed ID: 18486767
    [Abstract] [Full Text] [Related]

  • 19. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T, Koga M, Ishiguro H, Horiuchi Y, Syu A, Yoshio T, Takahashi N, Ozaki N, Arinami T.
    Pharmacogenet Genomics; 2008 Apr 01; 18(4):317-23. PubMed ID: 18334916
    [Abstract] [Full Text] [Related]

  • 20. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias.
    Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, Oliveira PS, Pereira AC, Krieger JE.
    J Hypertens; 2007 Sep 01; 25(9):1763-74. PubMed ID: 17762636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.